v3.25.2
Stockholders' Equity
 6 Months Ended
Jun. 30, 2025
Stockholders' Equity Note [Abstract]  
Stockholders' Equity

(12) Stockholders’ Equity

The following table shows changes in the number of shares of our outstanding common stock:

 

 

Six months ended June 30,

 

 

 

2025

 

 

2024

 

 

 

(In thousands)

 

Common stock, beginning of period

 

 

33,368

 

 

 

34,996

 

Shares of common stock issued when sales restrictions on restricted stock units
   (“RSUs”) lapsed and performance-based stock units (“PSUs”) were earned

 

 

109

 

 

 

124

 

Common stock retired

 

 

(932

)

 

 

(1,126

)

Common stock, end of period

 

 

32,545

 

 

 

33,994

 

 

The above table excludes RSUs, director deferred shares, and PSUs, which do not have voting rights. As sales restrictions on RSUs lapse and PSUs are earned, we issue common shares with voting rights. As of June 30, 2025, we had a total of 208,266 RSUs and director deferred shares outstanding and 44,548 PSUs outstanding. The PSU outstanding balance is based on the number of PSUs granted pursuant to the award agreements; however, the actual number of common shares earned could be higher or lower based on actual versus targeted performance. See Note 14 (Share-Based Transactions) for discussion of the PSU award structure.

On November 14, 2024, our Board authorized, and the Company announced, a share repurchase program for up to $450.0 million of our outstanding common stock for purchases from November 14, 2024 through December 31, 2025 (the “Share Repurchase Program”). Under the Share Repurchase Program, we repurchased 901,663 shares of our common stock in the open market for an aggregate purchase price of $247.1 million through June 30, 2025. Approximately $202.9 million remains available for repurchases of our outstanding common stock under the Share Repurchase Program as of June 30, 2025.